What's next for Digital Therapeutics after it all went PEAR shaped?
Lloyd Price
APRIL 17, 2023
Billion valuation and loss of a development deal with Otsuka Pharmaceuticals. Partnership and collaboration: Healthcare providers, pharmaceutical companies, and technology companies are likely to form more partnerships and collaborations to develop and commercialize DTx solutions. billion by 2026, growing at a CAGR of 17.8%
Let's personalize your content